Redwood Pharma AB: Styrelseledamoten Bengt Furberg avliden
March 18, 2019 11:11 amRedwood Pharma AB meddelar idag att bolaget nåtts av beskedet att styrelseledamoten Bengt Furberg hastigt avlidit. ”Bengt Furberg har varit... View Article
Archives
Bokslutskommuniké 2018
February 13, 2019 11:42 amRedwood Pharma AB (publ), Bokslutskommuniké 2018,1 januari – 31 december 2018 Perioden 1 januari – 31 december 2018 Bolagets nettoomsättning... View Article
Redwood Pharma to Attend BIO-Europe 2019, Mar. 25 – 27 in Vienna for Partnering Discussions
February 11, 2019 9:35 amRedwood Pharma will be attending BIO-Europe 2019 in Vienna, Mar. 25 – 27 to meet and continue discussions with potential... View Article
Redwood Pharma to Attend BIO-Europe 2019, Mar. 25 – 27 in Vienna for Partnering Discussions
February 11, 2019 9:35 amRedwood Pharma will be attending BIO-Europe 2019 in Vienna, Mar. 25 – 27 to meet and continue discussions with potential... View Article
First patient treated
February 4, 2019 8:00 amin Redwood Pharma Phase II study
First patient treated in Redwood Pharma Phase II study
February 4, 2019 8:00 amRedwood Pharma AB (publ) today announces that the first patient has begun testing ofRP101 in a Phase II clinical trial.... View Article
Första patienten har påbörjat behandling i Redwood Pharmas Fas II-prövning
February 4, 2019 8:00 amRedwood Pharma AB (publ) meddelar idag att första patienten har börjat behandlas i företagets Fas-II prövning. RP101 är en innovativ... View Article
Konvertering i Redwood Pharma
January 9, 2019 2:31 pmPressmeddelande 2019-01-09 Den 8 oktober 2018 beslutade Redwood Pharma AB (”Redwood”) om en till den danska fonden Formue Nord Markedsneutral... View Article
January 7, 2019 9:12 pm
Redwood Pharma receives its third and last national approval
Redwood Pharma receives its third and last national approval
January 7, 2019 9:07 pmRedwood Pharma has now also received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to initiate... View Article